NFKB1 and Miyoshi myopathy: Because this BMSC-secreted factor causes NF-κB activation in MM cells in a manner resistant to bortezomib [33], this would also represent the first known factor to induce proteasome inhibitor resistant (PIR) NF-κB activation in MM cells.